ARKG Investment Tracker position change: Increased position in Illumina by 815 shares, the number of shares held increased 0.53% compared to the previous period and now represents 1.28% of the total position.

ARKG Investment Tracker position change: Increased position in Ionis Pharmaceuticals by 5,305 shares, the number of shares held increased 0.53% compared to the previous period and now represents 3.04% of the total position.

ARKG Investment Tracker position change: Increased position in Intellia Therapeutics by 16,695 shares, the number of shares held increased 0.53% compared to the previous period and now represents 2.34% of the total position.

ARKG Investment Tracker position change: Increased position in Vertex Pharmaceuticals by 140 shares, the number of shares held increased 0.53% compared to the previous period and now represents 1.4% of the total position.

ARKG Investment Tracker position change: Increased position in 10x Genomics, Inc. by 15,975 shares, the number of shares held increased 0.53% compared to the previous period and now represents 2.53% of the total position.

ARKG Investment Tracker position change: Increased position in Incyte by 890 shares, the number of shares held increased 0.53% compared to the previous period and now represents 1.14% of the total position.

ARKG Investment Tracker position change: Increased position in Amgen by 315 shares, the number of shares held increased 0.53% compared to the previous period and now represents 1.95% of the total position.

ARKG Investment Tracker position change: Increased position in Veracyte by 6,640 shares, the number of shares held increased 0.53% compared to the previous period and now represents 4.07% of the total position.

ARKG Investment Tracker position change: Increased position in Beam Therapeutics, Inc. by 11,000 shares, the number of shares held increased 0.53% compared to the previous period and now represents 3.56% of the total position.

ARKG Investment Tracker position change: Increased position in Schrodinger Inc. by 12,165 shares, the number of shares held increased 0.53% compared to the previous period and now represents 4.64% of the total position.

ARKG Investment Tracker position change: Increased position in Guardant Health Inc. by 7,485 shares, the number of shares held increased 0.53% compared to the previous period and now represents 6.43% of the total position.

ARKG Investment Tracker position change: Increased position in Natera by 2,160 shares, the number of shares held increased 0.53% compared to the previous period and now represents 6.12% of the total position.

ARKG Investment Tracker position change: Increased position in CRISPR Therapeutics AG by 11,275 shares, the number of shares held increased 0.53% compared to the previous period and now represents 7.79% of the total position.

ARKG Investment Tracker position change: Increased position in Recursion Pharmaceuticals, Inc. by 67,930 shares, the number of shares held increased 0.53% compared to the previous period and now represents 6.1% of the total position.

ARKG Investment Tracker position change: Increased position in Tempus AI by 8,830 shares, the number of shares held increased 0.53% compared to the previous period and now represents 7.96% of the total position.

ARKG Investment Tracker position change: Increased position in Twist Bioscience Corp by 12,160 shares, the number of shares held increased 0.53% compared to the previous period and now represents 9.32% of the total position.

ARKG Investment Tracker position change: Increased position in Veeva by 290 shares, the number of shares held increased 0.53% compared to the previous period and now represents 1.31% of the total position.

ARKG Investment Tracker position change: Increased position in Pacific Biosciences of California by 62,665 shares, the number of shares held increased 0.53% compared to the previous period and now represents 1.63% of the total position.

ARKG Investment Tracker position change: Increased position in Regeneron Pharmaceuticals by 70 shares, the number of shares held increased 0.51% compared to the previous period and now represents 0.88% of the total position.

ARKG Investment Tracker position change: Decreased position in Intellia Therapeutics by 13,356 shares, the number of shares held decreased 0.42% compared to the previous period and now represents 2.34% of the total position.